Rankings
▼
Calendar
NAUT FY 2025 Earnings — Nautilus Biotechnology, Inc. Revenue & Financial Results | Market Cap Arena
NAUT
Nautilus Biotechnology, Inc.
$339M
FY 2025 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
-$6M
Operating Income
-$67M
Net Income
-$59M
EPS (Diluted)
$-0.47
Cash Flow
Operating Cash Flow
-$51M
Free Cash Flow
-$52M
Stock-Based Comp.
$7M
Balance Sheet
Total Assets
$191M
Total Liabilities
$34M
Stockholders' Equity
$157M
Cash & Equivalents
$12M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
-$6M
-$6M
-1.8%
Operating Income
-$67M
-$81M
+18.0%
Net Income
-$59M
-$71M
+16.6%
← Q4 2024
All Quarters
Q1 2025 →